Duncan Kennedy.
Head of Interventional Oncology
Interventional Oncology
BTG plc
Australia
Biography
Duncan Kennedy joined BTG in December 2005 as Group Financial Controller and joined the Leadership Team in April 2012 following his appointment as Group Director of Finance, having management responsibility for the global finance function, supporting the CFO. Duncan was appointed to his current role leading the Interventional Oncology business in May 2015. Prior to joining BTG, Duncan spent six years in the group finance function of Wembley plc, an international leisure group, gaining wide-ranging experience in all aspects of listed company financial reporting and significant involvement in corporate transactions. Duncan qualified as a Chartered Accountant at Arthur Andersen and holds a BSc in Mathematics from Durham University.
Research Interest
Mathematics